EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting HLA‐E in Lung Cancer: The Therapeutic Potential of IRF5‐Engineered M1‐Macrophage‐Derived Exosomes

Xuqin Feng, Xiangyu Lai, Mingming Zhou, Jun Bie, Tingting Li, Dan Wang, Silin Chen, Xin Hu, Chunyu Wang, Peng Xu iD

The Clinical Respiratory Journal · 2024

DOI: 10.1111/crj.70035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Clinical Respiratory Journal, 2024. Verfasst von Xuqin Feng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Beijing Anzhen Nanchong Hospital, Capital Medical University (Nanchong Central Hospital), The Second Clinical Medical College…. Hauptthemen laut MEDLINE: Exosomes, Lung Neoplasms, Macrophages, Interferon Regulatory Factors. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Department Project of Sichuan Province, Nanchong Federation of Social Science Associations.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy is a pivotal approach in the treatment of lung cancer. Although HLA‐E is a potential target for tumor immunotherapy, its role in lung cancer remains unclear. Previous studies have identified the transcription factor IRF5 as a characteristic gene of M1‐like macrophages, highlighting its crucial role in promoting antitumor immune responses. In this study, we developed an engineered M1‐like macrophage exosomes expressing IRF5 (IRF5 M1‐exos) and demonstrated their ability to inhibit proliferation, migration, and invasion of lung cancer cells. Moreover, our experiments using a nude mouse model revealed that IRF5 M1‐exos exerted potent therapeutic effects by effectively suppressing tumor growth. Notably, the mechanism by which IRF5 exerts its antitumor function through HLA‐E regulation in lung cancer has not been fully elucidated. Here, we identified HLA‐E as a downstream target gene of IRF5 and demonstrated that the overexpression of HLA‐E can counteract the tumor‐promoting effects induced by si‐IRF5 M1‐exos. These results suggest that M1 macrophage‐derived exosomes, enriched with the transcription factor IRF5, exhibit potent antitumor activity by up‐regulating HLA‐E in lung cancer cells. Therefore, IRF5 M1‐exos represent an attractive therapeutic strategy for lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesLung NeoplasmsMacrophagesInterferon Regulatory FactorsAnimalsMiceHumansCell ProliferationMice, NudeHistocompatibility Antigens Class ICell Line, TumorCell MovementImmunotherapyGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

HLA‐Eexosomelung cancermacrophagetranscription factor

Substanzen

IRF5 protein, humanInterferon Regulatory FactorsHistocompatibility Antigens Class I

Autor:innen und Institutionen

  • Department of Oncology, Beijing Anzhen Nanchong Hospital, Capital Medical University (Nanchong Central Hospital), The Second Clinical Medical College of North Sichuan Medical College, Nanchong, Sichuan, China.
  • Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing Cancer Hospital, Chongqing Cancer Institute, Chongqing, China.
  • Department of Clinical Laboratory, Beibei Traditional Chinese Medical Hospital, Chongqing, China.

ORCID-Profile: Peng Xu

Förderung

  • Science and Technology Department Project of Sichuan Province
  • Nanchong Federation of Social Science Associations

Zitieren

APA

Feng, X., Lai, X., Zhou, M., Bie, J., Li, T., Wang, D., Chen, S., Hu, X., Wang, C., & Xu, P. (2024). Targeting HLA‐E in Lung Cancer: The Therapeutic Potential of IRF5‐Engineered M1‐Macrophage‐Derived Exosomes. The Clinical Respiratory Journal. https://doi.org/10.1111/crj.70035

Vancouver

Feng X, Lai X, Zhou M, Bie J, Li T, Wang D, et al. Targeting HLA‐E in Lung Cancer: The Therapeutic Potential of IRF5‐Engineered M1‐Macrophage‐Derived Exosomes. The Clinical Respiratory Journal. 2024. doi:10.1111/crj.70035

BibTeX
@article{Feng2024,
  author = {Feng, Xuqin and Lai, Xiangyu and Zhou, Mingming and Bie, Jun and Li, Tingting and Wang, Dan and Chen, Silin and Hu, Xin and Wang, Chunyu and Xu, Peng},
  title = {Targeting HLA‐E in Lung Cancer: The Therapeutic Potential of IRF5‐Engineered M1‐Macrophage‐Derived Exosomes},
  journal = {The Clinical Respiratory Journal},
  year = {2024},
  doi = {10.1111/crj.70035}
}
Kostenlos starten →